CLINICAL CHARACTERISTICS OF THE NEW CORONAVIRUS INFECTION СOVID-19 IN PREGNANT WOMEN
Main Article Content
Abstract
According to the Federal State Statistics Service, maternal mortality in the Russian Federation increased from 9.0 to 11.2 in 2020; in some subjects of the Russian Federation, this figure rises to 18.9, indicating the need for further analysis and implementation of the latest scientific data into practice. This review presents data from current publications on the clinical manifestations of coronavirus infection in pregnant women, problems of radiation diagnosis, and pregnancy complications. Among the latter, thromboembolic events, placental disorders caused by microthrombosis and the resulting increase in preterm labor and hypertensive disorders are the most common. A threefold increase in gestational hypertension and the development of preeclampsia in pregnant women infected with COVID-19 has been reported. Each day more and more evidence are comming for the effectiveness of low molecular weight heparins for the prevention of perinatal complications. Data are presented on the possible effect of additional folate and vitamin D supplementation on the course of new coronavirus infection in pregnant women. The issues of perinatal outcomes and prevention of complications remain the most relevant and require further study.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Pettirosso E, Giles M, Cole S, Rees M. COVID-19 and pregnancy: A review of clinical characteristics, obstetric outcomes and vertical transmission. Aust N Z J Obstet Gynaecol. 2020; 60(5): 640-659. doi: 10.1111/ajo.13204
Guidelines for the organization of medical care for pregnant women, women in childbirth, puerperas and newborns with a new coronavirus infection (NCI) COVID-19 (version 4 of 07.05.2021) Russian (Методические рекомендации по организации оказания медицинской помощи беременным, роженицам, родильницам и новорожденным при новой коронавирусной инфекции (НКИ) COVID-19 (версия 4 от 05.07.2021 г.)
Version 14: updated 25 August 2021. Guidance for healthcare professionals on coronavirus (COVID-19) infection in pregnancy, including guidance on vaccination in pregnancy, published by the RCOG, Royal College of Midwives, Royal College of Paediatrics and Child Health, Public Health England and Public Health Scotland
Arora R, Marwah S, Dhama V, Dabral A, Gupta N, Arora B. COVID-19 in pregnancy: A preliminary 50-day review from India. J Family Med Prim Care. 2021; 10(2): 883-892. doi:10.4103/jfmpc.jfmpc_1471_20
Jafari M, Pormohammad A, Sheikh NSA, Ghorbani S, Bose D, Alimohammadi S, et al. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis. Rev Med Virol. 2021; 31(5): 1-16. doi: 10.1002/rmv.2208
Materials of the conference of the Russian Association of Human Reproduction (RAHR). Reproductive health and the COVID-19 epidemic: one year later. 06.08.2021. Russian (Материалы конференции Российской ассоциации репродукции человека (РАРЧ). Репродуктивное здоровье и эпидемия COVID-19: год спустя. 08.06.2021)
Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020; 370: m3320. doi:10.1136/bmj.m3320
Knight M, Bunch K, Vousden N, Morris E, Simpson N, Gale C et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020; 369: m2107. doi:10.1136/bmj.m2107
COVID in Pregnancy Tied to Hypertension, Preeclampsia /Society for Maternal-Fetal Medicine (SMFM) 2021 Annual Pregnancy Meeting: Abstract 32. Presented January 28, 2021. Tara Haelle. February 02, 2021 – Medscape
Jering KS, Claggett BL, Cunningham JW, Rosenthal N, Vardeny O, Greene MF, Solomon SD. Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19. JAMA Intern Med. 2021; 181(5): 714-717. doi: 10.1001/jamainternmed.2020.9241
Francis S, Mathew RP, Khalid ZA. Coronavirus (COVID-19) Infection in Pregnancy: Does Non-contrast Chest Computed Tomography (CT) Have a Role in Its Evaluation and Management? J Obstet Gynaecol India. 2020; 70(4): 272-274. doi: 10.1007/s13224-020-01341-5
Chen D, Yang H, Cao Y, Cheng W, Duan T, Fan C, et al. Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection. Int J Gynaecol Obstet. 2020; 149(2): 130-136. doi: 10.1002/ijgo.13146
Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19). https://www.acog.org/-/media/project/acog/acogorg/files/pdfs/clinical-guidance/practice-advisory/covid-19-algorithm.pdf. Accessed 30 May 2020
Bouachba A, Allias F, Nadaud B, Massardier J, Mekki Y, Bouscambert DM, et al. Placental lesions and SARS-Cov-2 infection: Diffuse placenta damage associated to poor fetal outcome. Placenta. 2021; 112: 97-104. doi: 10.1016/j.placenta.2021.07.288
Schwartz DA, Morotti D. Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2. Viruses. 2020; 12(11): 1308. doi: 10.3390/v12111308
Shanes ED, Mithal LB, Otero S, Azad HA, Miller ES, Goldstein JA. Placental Pathology in COVID-19. Am J Clin Pathol. 2020; 154(1): 23-32. doi:10.1093/ajcp/aqaa089
Liu N, Sun J, Wang X, Zhang T, Zhao M, Li H. Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis. Int J Infect Dis. 2021; 104: 58-64. doi: 10.1016/j.ijid.2020.12.077
Herrera-Quintana L, Gamarra-Morales Y, Vázquez-Lorente H, Molina-López J, Castaño-Pérez J, Machado-Casas JF, et al. Bad Prognosis in Critical Ill Patients with COVID-19 during Short-Term ICU Stay regarding Vitamin D Levels. Nutrients. 2021; 13(6): 1988. doi: 10.3390/nu13061988
Ben-Eltriki M, Hopefl R, Wright JM, Deb S. Association between Vitamin D Status and Risk of Developing Severe COVID-19 Infection: A Meta-Analysis of Observational Studies. J Am Coll Nutr. 2021; 31: 1-11. doi: 10.1080/07315724.2021.1951891
Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A. Physiological changes in pregnancy. Cardiovasc J Afr. 2016; 27(2): 89-94. doi: 10.5830/CVJA-2016-021
Kadir RA, Kobayashi T, Iba T, Erez O, Thachil J, Kazi S, et al. COVID-19 coagulopathy in pregnancy: Critical review, preliminary recommendations, and ISTH registry-Communication from the ISTH SSC for Women's Health. J Thromb Haemost. 2020; 18(11): 3086-3098. doi: 10.1111/jth.15072
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844-847. doi: 10.1111/jth.14768
Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009; 114(6): 1326-1331. doi: 10.1097/AOG.0b013e3181c2bde8
Ercan Ş, Özkan S, Yücel N, Orçun A. Establishing reference intervals for D-dimer to trimesters. J Matern Fetal Neonatal Med. 2015; 28(8): 983-987. doi: 10.3109/14767058.2014.940891
Gutiérrez GI, Pérez CP, Martínez UJ, García IO, Angeles JPM, García de Guadiana RL. D-dimer during pregnancy: establishing trimester-specific reference intervals. Scand J Clin Lab Invest. 2018; 78(6): 439-442. doi: 10.1080/00365513.2018.1488177
Tripodi A, Lippi G, Plebani M. How to report results of prothrombin and activated partial thromboplastin times. Clin Chem Lab Med. 2016; 54(2): 215-222. doi: 10.1515/cclm-2015-0657
Liu J, Yuan E, Lee L. Gestational age-specific reference intervals for routine haemostatic assays during normal pregnancy. Clin Chim Acta. 2012; 413(1-2): 258-61. doi: 10.1016/j.cca.2011.09.046
Vlachodimitropoulou KE, Vivanti AJ, Shehata N, Benachi A, Le Gouez A, Desconclois C, et al. COVID-19 and acute coagulopathy in pregnancy. J Thromb Haemost. 2020; 18(7): 1648-1652. doi: 10.1111/jth.14856
Hunt B, Retter A, McClintock C. 2020. Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19. Thrombosis UK. Available from: https://thrombosisuk.org/covid-19-thrombosis.php. [Google Scholar]
The COVID-19 Sub-Committee of the American Venous Forum Considerations in prophylaxis and treatment of VTE in COVID-19 patients; 2020. https://www.veinforum.org/wp-content/uploads/2020/04/COVID-19-White-Paper-04-17-2020-FINAL-1.pdf
Al-Matary A, Almatari F, Al-Matary M, AlDhaefi A, Alqahtani MHS, Alhulaimi EA, et al. Clinical outcomes of maternal and neonate with COVID-19 infection – Multicenter study in Saudi Arabia. J Infect Public Health. 2021; 14(6): 702-708. doi: 10.1016/j.jiph.2021.03.013. Epub 2021 Apr 20
Kravchenko EN, Kuklina LV, Ovchinnikova EM, Chebakova VYu, Vyzhlova EN, Baranov II. COVID-19 in pregnancy: special characteristics of the course and rational therapy with recombinant interferon alfa-2b formulations. Russian Bulletin of Obstetrician-Gynecologist. 2021; 21(5): 96-101. Russian (Кравченко Е.Н., Куклина Л.В., Овчинникова Е.М., Чебакова В.Ю., Выжлова Е.Н., Баранов И.И. COVID-19 во время беременности: особенности течения и рациональная терапия с использованием препаратов рекомбинантного интерферона альфа-2b //Российский Вестник акушера-гинеколога. 2021. Т. 21, № 5. С. 96-101.) https://doi.org/10.17116/rosakush20212105196
Penfield CA, Brubaker SG, Limaye MA, Lighter J, Ratner AJ, Thomas KM, et al. Detection of SARS-COV-2 in placental and fetal membrane samples. Am J Obstet Gynecol. MFM. 2020; 2(3): 100133. https://doi.org/10.1016/j.ajogmf.2020.100133
Kuklina LV, Kravchenko EN, Ozherelyeva MA, Zadorozhnaya EA, Vyzhlova EN, Baranov II. Risk factors for acute respiratory viral infections in pregnant women. Effectiveness of preventive measures. Gynecology, Obstetrics and Perinatology. 2021; 20(3): 85-91. Russian (Куклина Л.В., Кравченко Е.Н., Ожерельева М.А., Задорожная Е.А., Выжлова Е.Н., Баранов И.И. Факторы риска заболеваемости острыми респираторными вирусными инфекциями у беременных. Эффективность профилактических мер //Вопросы гинекологии, акушерства и перинатологии. 2021. Т. 20, № 3. С. 85-91.) doi: 10.20953/1726-1678-2021-3-85-91